Germany
Japan
United Kingdom
China
CD61 (ITGB3) mouse monoclonal antibody, clone VIPL2, Aff - Purified
| Applications | FC, IHC, WB |
| Reactivities | Human, Primate |
Research Areas
View as table Download
CD130 (IL6ST) mouse monoclonal antibody, clone B-P4, Azide Free
| Applications | FC, FN, IHC, IP, WB |
| Reactivities | Human |
Rabbit polyclonal HLA-G Antibody (Center)
| Applications | FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This HLA-G antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 62-89 amino acids from the Central region of human HLA-G. |
Rabbit Polyclonal Antibody against CD19 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD19 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 143-172 amino acids from the N-terminal region of human CD19. |
Rabbit polyclonal PECAM-1 (Ab-713) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human PECAM-1 around the phosphorylation site of tyrosine 713 (T-V-YP-S-E). |
Rabbit polyclonal ROR2 Antibody (N-term)
| Applications | FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ROR2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 19-50 amino acids from the N-terminal region of human ROR2. |
Rabbit Polyclonal CD4 Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat, Rabbit |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to an C-terminal region of the human CD4 protein (within residues 400-458). [Swiss-Prot P01730] |
Rabbit polyclonal IL1R Antibody (C-term E487)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This IL1R antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 474-503 amino acids from the C-terminal region of human IL1R. |
Frizzled 2 (FZD2) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Immunogen | Peptide with sequence from the internal region of the protein sequence according to NP_001457.1. |
Goat Anti-CD20 / MS4A1 (C Terminus) Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CQDQESSPIENDSSP, from the C Terminus of the protein sequence according to NP_068769.2; NP_690605.1. |
Rabbit polyclonal antibody to CD41/Integrin alpha 2b (integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41))
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 210 and 532 of Integrin alpha 2b (Uniprot ID#P08514) |
Rabbit Polyclonal Antibody against CD8A (N-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This CD8A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 59-88 amino acids from the N-terminal region of human CD8A. |
Rabbit polyclonal PECAM-1 (Tyr713) antibody(Phospho-specific)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PECAM-1 around the phosphorylation site of tyrosine 713 (T-V-YP-S-E). |
| Modifications | Phospho-specific |
NCAM1/CD56 mouse monoclonal antibody, clone OTI2D4 (formerly 2D4)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Applications
- WB
Families
- Transmembrane
Citations
- Yes
Filter by
Category
Target Symbol
Reactivities
Antibody Hosts
Isotypes
Clonalities
Conjugates
Modifications
Pathways
- Hematopoietic cell lineage (40)
- Cell adhesion molecules (CAMs) (32)
- Primary immunodeficiency (19)
- T cell receptor signaling pathway (17)
- Antigen processing and presentation (11)
- Alzheimer's disease (8)
- Leukocyte transendothelial migration (8)
- B cell receptor signaling pathway (7)
- Renin-angiotensin system (7)
- Cytokine-cytokine receptor interaction (5)
- Allograft rejection (4)
- Dilated cardiomyopathy (4)
- Graft-versus-host disease (4)
- Hypertrophic cardiomyopathy (HCM) (4)
- Pathways in cancer (4)
- Prion diseases (4)
- Toll-like receptor signaling pathway (4)
- Type I diabetes mellitus (4)
- Apoptosis (3)
- Asthma (3)
- Basal cell carcinoma (3)
- Colorectal cancer (3)
- Lysosome (3)
- MAPK signaling pathway (3)
- Melanogenesis (3)
- Natural killer cell mediated cytotoxicity (3)
- Systemic lupus erythematosus (3)
- Wnt signaling pathway (3)
- Adipocytokine signaling pathway (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (2)
- Autoimmune thyroid disease (2)
- ECM-receptor interaction (2)
- Fc epsilon RI signaling pathway (2)
- Focal adhesion (2)
- NOD-like receptor signaling pathway (2)
- RIG-I-like receptor signaling pathway (2)
- Regulation of actin cytoskeleton (2)
- TGF-beta signaling pathway (2)
- Type II diabetes mellitus (2)
- Viral myocarditis (2)
- Endocytosis (1)
- Glutathione metabolism (1)
- Jak-STAT signaling pathway (1)
- Metabolic pathways (1)
- Pathogenic Escherichia coli infection (1)
- Small cell lung cancer (1)